Business
Admittance to trading on the OTCQB Venture Market
Admittance to trading on the OTCQB Venture Market.
About this update from Bsf Enterprise Plc
[{"type":"text","content":"\n\n25 May 2023\n \nBSF Enterprise PLC\n(\"BSF\" or the \"Company\")\n \nAdmittance to trading on the OTCQB Venture Market\n \nBSF (LSE: BSFA), (OTCQB: BSFAF), the Main Market listed biotech company and the owner of pioneering UK-based clinical and cellular agriculture company 3D Bio-Tissues, is pleased to announce that the Company's Ordinary Shares (\"Ordinary Shares\") were admitted to trading on the OTCQB Venture Market in the United States on 24 May 2023. The shares trade under the symbol BSFAF.\n \nTrading on the OTCQB market provides BSF with access to one of the world's largest investment markets, expanding the Company's reach to a broader pool of investors while creating the potential for greater liquidity in its shares. Shares will also be available to US investors during US trading hours, priced in US dollars. This will ease cross-border trading, with the potential to further enhance liquidity.\n \nThere is no capital raise associated with BSF trading on the OTCQB market and BSF's Ordinary Shares will continue to trade on its primary listing, the Main Market of the London Stock Exchange, under the ticker BSFA.\n \nChe Connon, Managing Director of BSF Enterprise and CEO at 3D Bio Tissues, commented: \"We are delighted to have joined the OTCQB market. This is an important step for BSF which provides access to a wider investor audience from which to raise funds and improve liquidity. In addition, it will help to raise our profile in the US and beyond, a timely development given that we are in the process of establishing sales channels across key global markets including the US. This was demonstrated in our announcement released earlier this week, detailing the headway we are already making in delivering new contracts and distribution partners. Together, these developments give us confidence in our ability to drive additional momentum in the coming months.\"\n \nFurther Information on BSF's application and the OTCQB market below:\n \nAs a Foreign Private Issuer, BSF's onboarding to the OTC Markets is based on satisfaction of the requirements for OTCQB as applicable to international reporting companies including satisfaction of the criteria for the exemption under the US Exchange Act Rule 12g3-2(b) from SEC reporting. The Rule 12g3-2(b) exemption includes the disclosure obl...